Glycemic variability is associated with myocardial damage in nondiabetic patients with ST-elevation myocardial

Satoshi Oka1, Juntaro Deyama1, Ken Umetani1

  • 1Department of Cardiology, Yamanashi Prefectural Central Hospital, Kofu, Yamanashi Prefecture, Japan.

Insights

Glycemic variability (GV) is linked to myocardial damage in non-diabetic patients post-percutaneous coronary intervention for myocardial infarction. Higher GV correlated with worse outcomes, suggesting GV is a significant factor in this patient group.

Area of Science:

  • Cardiology
  • Endocrinology
  • Medical Research

Background:

  • Glycemic variability (GV) is known to cause coronary microcirculatory disturbance and myocardial damage in diabetic patients with acute myocardial infarction.
  • The association between GV and myocardial damage in non-diabetic patients with acute myocardial infarction is not well understood.

Purpose of the Study:

  • To investigate the relationship between glycemic variability and myocardial damage in non-diabetic patients with ST-segment elevation myocardial infarction (STEMI).

Main Methods:

  • A continuous glucose monitoring system was used to assess GV in non-diabetic STEMI patients undergoing emergent percutaneous coronary intervention.
  • GV was quantified using the mean amplitude of glycemic excursions (MAGE).
  • Myocardial damage was evaluated by myocardial blush grade and ST-segment resolution (STRes).

Main Results:

  • The higher MAGE group exhibited significantly lower myocardial blush grade (p=0.001) and poorer ST-segment resolution (p=0.044) compared to the lower MAGE group.
  • Specifically, complete STRes was less frequent in the higher MAGE group (33.3% vs. 56.8%).
  • The higher MAGE group also showed a trend towards more instances of no STRes (30.6% vs. 10.8%).

Conclusions:

  • Glycemic variability is associated with myocardial damage in non-diabetic patients following percutaneous coronary intervention for ST-segment elevation myocardial infarction.
  • These findings highlight the importance of managing GV in this patient population to potentially improve cardiac outcomes.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
186
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
320
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
149
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
321
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
226
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.7K